Stockholders' Equity (Details Narrative) (USD $)	3 Months Ended	9 Months Ended		6 Months Ended	12 Months Ended		6 Months Ended	12 Months Ended	6 Months Ended	12 Months Ended	9 Months Ended	12 Months Ended	6 Months Ended	9 Months Ended	12 Months Ended	6 Months Ended	9 Months Ended	12 Months Ended	6 Months Ended	12 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013	Dec. 31, 2012	Jun. 30, 2013 Management Stock Options	Dec. 31, 2012 Management Stock Options	Dec. 31, 2012 Convertible Promissory Note	Jun. 30, 2013 Warrant Grants - Transition Partners, Limited	Dec. 31, 2012 Warrant Grants - Transition Partners, Limited	Jun. 30, 2013 Warrant Grants - AVIDBank	Dec. 31, 2011 Warrant Grants - AVIDBank	Sep. 30, 2013 Warrant Grants - Breakwater Structured Growth Opportunity Fund	Dec. 31, 2011 Warrant Grants - Breakwater Structured Growth Opportunity Fund	Jun. 30, 2013 Warrant Grants - Microcap Headlines, Inc.	Sep. 30, 2013 Option Grant - Jerry Falkner	Dec. 31, 2012 Option Grant - Jerry Falkner	Jun. 30, 2013 Option Grant - Company Employees	Sep. 30, 2013 Option Grant - Company Employees	Dec. 31, 2012 Option Grant - Company Employees	Jun. 30, 2013 Option Grant - Consultants	Dec. 31, 2012 Option Grant - Consultants	Sep. 30, 2013 Warrant Grants - Optivest Global Partners, LLC
Stock options issued					823,757										125,000		50,000	54,479		100,000
Stock options exercise price					$ 0.573										$ 2.25		$ 2.10	$ 2.25		$ 2.5
Stock issued upon conversion of notes payable						329,502
Stock warrants issued																					250,000
Stock warrants granted								123,563		33,401		420,549	100,000
Stock warrants issued exercise price								0.57					2.25								2.25
Irrevocable put right												The company is obligated to honor an irrevocable put right which the company agreed to purchase up to the 3% of fully diluted shares of its common stock underlying the warrant which expires on July 15, 2016.
Current stock value	$ 0.01	$ 0.01	$ 0.01
Stock options and warrants granted expiration date								Jul. 31, 2015		Jun. 17, 2016		Jun. 15, 2016	Jan. 01, 2018	Sep. 05, 2017		Sep. 27, 2022	Sep. 17, 2023		Nov. 30, 2022		Jul. 16, 2018
Stock options and warrants vesting period										Fully vested		Fully vested	One-fourth quarterly increments. First increment was granted and fully vested on January 1, 2013, the second was granted and fully vested on April 1, 2013, third increment was granted and fully vested on July 1, 2013.	All four increments were fully vested	Options were subject to a conditional vesting schedule, in one-fourth increments. The first installment vested and became exercisable upon execution of the consulting contract on September 6, 2012. The second installment upon the publication of the first "Research Profile" report, which was completed November 30, 2012, the third installment vested on February 28, 2013, 90 days following the publication of the aforementioned report, and the fourth installments will vest 180 days following the publication of the report.	Three year vesting schedules of 1/3 each year through September 2015.	Three year vesting schedules of 1/3 each year through September 2016		Three year vesting schedule in one-third increments. The first vesting period begins on November 30, 2013.		Fully vested
Discount assumption											50.00%										24.00%
Risk free interest rate, minimum											0.63%										1.38%
Risk free interest rate, maximum																					2.26%
Stock price																					$ 1.63
Stock price, range											1.0657952 to 0.93826656
Risk neutral probabilities, range											0.48502515 to 0.51497485
Weighted average expected terms											2.79 years										Terms ranging from 4.5 to 6.0 years
Expected volatility											45.95%										45.95%
Stock option valuation expense allocated to other income expense	$ 160,182	$ 358,943
Stock issued upon cashless exercise of warrants				111,731			103,762		33,401
Derivative liability, reclassified									$ 87,755